{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:40:06Z","timestamp":1759333206279},"reference-count":25,"publisher":"Informa Healthcare","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1185\/030079904125004448","type":"journal-article","created":{"date-parts":[[2005,1,20]],"date-time":"2005-01-20T10:46:04Z","timestamp":1106217964000},"page":"1341-1345","source":"Crossref","is-referenced-by-count":13,"title":["Ocular hypotensive efficacy of travoprost in patients unsuccessfully treated with latanoprost"],"prefix":"10.1185","volume":"20","author":[{"given":"Martin","family":"Kaback","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Geanon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Ripkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Przydryga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"the START Study","family":"Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2004,7,22]]},"reference":[{"key":"CIT0002","first-page":"527","volume":"23","author":"Alm A","year":"1995","journal-title":"Adv Prostaglandin Thromboxane Leukot Res"},{"key":"CIT0004","first-page":"138","volume":"103","author":"Camras CB","year":"1996","journal-title":"[The United States Latanoprost Study Group]. Ophthalmology"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.1996.tb00058.x"},{"key":"CIT0006","first-page":"126","volume":"103","author":"Watson P","year":"1996","journal-title":"[The Latanoprost Study Group]. Ophthalmology"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(01)00584-X"},{"key":"CIT0008","first-page":"S353\u2013S360","volume":"45","author":"DuBiner H","year":"2001","journal-title":"a 30-day comparison with latanoprost. Survey Ophthalmol"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1007\/BF02850299"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(01)00219-3"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.10.1286"},{"key":"CIT0012","first-page":"414","volume":"10","author":"Goldberg I","year":"2001","journal-title":"5% given twice daily in patients with open-angle glaucoma or ocular hypertension. J Glaucoma"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(01)01177-1"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(02)01891-2"},{"key":"CIT0017","first-page":"845","volume":"281","author":"Griffin BW","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"CIT0018","first-page":"411","volume":"286","author":"Griffin BW","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"CIT0019","first-page":"1094","volume":"286","author":"Sharif NA","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1089\/108076801753266802"},{"key":"CIT0021","first-page":"715","volume":"44","author":"Sharif NA","year":"2003","journal-title":"Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues. Invest Ophthalmol Vis Sci"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1089\/108076803322473006"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.10.1268"},{"key":"CIT0025","first-page":"429","volume":"130","author":"The AGIS Investigators","year":"2000","journal-title":"The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.6.701"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.10.1371"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1089\/108076803322472971"},{"key":"CIT0029","first-page":"23","volume":"196","author":"Novack GD","year":"1988","journal-title":"Effect of changing medication regimens in glaucoma patients. Ophthalmologica"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)83063-5"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/030079904125004448","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T03:42:05Z","timestamp":1481600525000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1185\/030079904125004448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,22]]},"references-count":25,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2004,7,14]]},"published-print":{"date-parts":[[2004,9]]}},"alternative-id":["10.1185\/030079904125004448"],"URL":"https:\/\/doi.org\/10.1185\/030079904125004448","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,22]]}}}